Article Details

SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies to Advance ...

Retrieved on: 2021-03-18 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies to Advance .... View article details on hiswai:

Excerpt

SpyBiotech is focused on the development of a novel vaccine platform technology targeting infectious diseases, cancer and chronic diseases. The ...

Article found on: www.galvnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up